These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2185101)

  • 1. Carcinogenicity of peroxisome proliferators: evaluation and mechanisms.
    Reddy JK
    Biochem Soc Trans; 1990 Feb; 18(1):92-4. PubMed ID: 2185101
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of rodent liver carcinogenesis.
    Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
    Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroxisomes and peroxisome proliferators. Specific environmental poisons and therapeutic agents affecting lipid metabolism and hormone release].
    Hammer TA; Waldum HL
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3603-8. PubMed ID: 9820005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.
    Reddy JK; Azarnoff DL; Hignite CE
    Nature; 1980 Jan; 283(5745):397-8. PubMed ID: 6766207
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization.
    Cattley RC; Glover SE
    Carcinogenesis; 1993 Dec; 14(12):2495-9. PubMed ID: 8269617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype.
    Reddy JK; Scarpelli DG; Subbarao V; Lalwani ND
    Toxicol Pathol; 1983; 11(2):172-80. PubMed ID: 6399165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    Jpn J Cancer Res; 1990 Mar; 81(3):213-5. PubMed ID: 2112523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phthalate esters as peroxisome proliferator carcinogens.
    Warren JR; Lalwani ND; Reddy JK
    Environ Health Perspect; 1982 Nov; 45():35-40. PubMed ID: 6754363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
    Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
    Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferators and signal transduction.
    Bronfman M; Nuñez L; Orellana A; Burzio V; Hidalgo P
    Ann N Y Acad Sci; 1996 Dec; 804():403-12. PubMed ID: 8993559
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
    Lake BG
    Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.
    Conway JG; Cattley RC; Popp JA; Butterworth BE
    Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of oxidative stress in non-genotoxic carcinogenesis with special reference to liver tumors induced by peroxisome proliferators.
    Sai-Kato K; Takagi A; Umemura T; Hasegawa R; Kurokawa Y
    Biomed Environ Sci; 1995 Sep; 8(3):269-79. PubMed ID: 8561928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
    [No Abstract]   [Full Text] [Related]  

  • 17. Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout.
    Orner GA; Mathews C; Hendricks JD; Carpenter HM; Bailey GS; Williams DE
    Carcinogenesis; 1995 Dec; 16(12):2893-8. PubMed ID: 8603461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferation and hepatocarcinogenesis.
    Reddy JK; Rao MS
    IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.